BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 1948277)

  • 1. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
    Boudreau EF; Pang LW; Chaikummao S; Witayarut C
    Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
    Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D
    Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
    Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand.
    Eamsila C; Singharaj P; Yooyen P; Chatnugrob P; Nopavong Na Ayuthya A; Webster HK; Lasserre R; Mittelholzer ML; Stürchler D
    Southeast Asian J Trop Med Public Health; 1993 Dec; 24(4):672-6. PubMed ID: 7939938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of falciparum malaria to different antimalarials in Myanmar.
    Ejov MN; Tun T; Aung S; Sein K
    Bull World Health Organ; 1999; 77(3):244-9. PubMed ID: 10212515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mefloquine--its 20 years in the Thai Malaria Control Program.
    Wongsrichanalai C; Prajakwong S; Meshnick SR; Shanks GD; Thimasarn K
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):300-8. PubMed ID: 15691128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/pyrimethamine (MSP) treatment among gem miners returning from Cambodia.
    Thimasarn K; Sirichaisinthop J; Vijaykadga S; Tansophalaks S; Yamokgul P; Laomiphol A; Palananth C; Thamewat U; Tháithong S; Rooney W
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):204-12. PubMed ID: 8629047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol).
    Pearlman EJ; Doberstyn EB; Sudsok S; Thiemanun W; Kennedy RS; Canfield CJ
    Am J Trop Med Hyg; 1980 Nov; 29(6):1131-7. PubMed ID: 7004214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of long-term prophylaxis with fansidar: a randomized double-blind study in Nigeria.
    Stemberger H; Leimer R; Wiedermann G
    Acta Trop; 1984 Dec; 41(4):391-9. PubMed ID: 6152120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
    Marquiño W; MacArthur JR; Barat LM; Oblitas FE; Arrunátegui M; Garavito G; Chafloque ML; Pardavé B; Gutierrez S; Arróspide N; Carrillo C; Cabezas C; Ruebush TK
    Am J Trop Med Hyg; 2003 Jan; 68(1):120-3. PubMed ID: 12557836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of combination fansidar-sulphate quinine and fansidar-chloroquine in mixed malaria infections of P. falciparum-P. vivax in children.
    Liando A; Rampengan TH
    Paediatr Indones; 1991; 31(3-4):99-103. PubMed ID: 1956694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
    Botero D; Restrepo M; Montoya A
    Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of malaria in north-eastern and south-eastern Nigeria: a population study of mefloquine, sulphadoxine, pyrimethamine combination (MSP) vs chloroquine (CQ).
    Ekanem OJ; Ezedinachi EN; Molta NB; Watila IM; Chukwuani CM; Meremikwu MM; Akpede G; Ojar EA
    West Afr J Med; 2000; 19(4):293-7. PubMed ID: 11391844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mefloquine level monitoring in patients with multidrug resistant Plasmodium falciparum on the Thai Myanmar border.
    Karbwang J; Bangchang KN; Thimasarn K; Rooney W; Bunnag D; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):505-7. PubMed ID: 8160060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.